Tobi 28 MG Inhalation Powder Capsule

RxCUI: 1374573
RxNorm name: Tobi 28 MG Inhalation Powder Capsule
Display name: Tobi 28 MG Inhalation Powder Capsule
Full name: Tobi 28 MG Inhalation Powder Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TOBI Podhaler	TOBRAMYCIN	Viatris Specialty LLC	c4b5bb1f-e158-4ac1-9c35-e98a416c743a	2026-04-15	Warnings, Adverse reactions	Exact identifier rxcui: 1374573

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c4b5bb1f-e158-4ac1-9c35-e98a416c743a	Tobi 28 MG Inhalation Powder Capsule [PSN] · tobramycin 28 MG Inhalation Powder [Tobi] [SBD] · Tobi 28 MG Inhalation Powder [SY]	3	12	These highlights do not include all the information needed to use TOBI PODHALER safely and effectively. See full prescribing information for TOBI PODHALER. TOBI ® PODHALER ® (tobramycin inhalation powder), for oral inhalation use Initial U.S. Approval: 1975	20230215